Post by Sobi - Swedish Orphan Biovitrum AB (publ)

Name: Today, we published our report for the second quarter of 2026, reflecting continued progress across
Uploaded: 2026-07-16T06:30:19.578Z
Channel: Sobi - Swedish Orphan Biovitrum AB (publ)
Description: Today, we published our report for the second quarter of 2026, reflecting continued progress across our business and pipeline. We made meaningful progress in bringing our medicines to more patients a

153,585 followers

Today, we published our report for the second quarter of 2026, reflecting continued progress across our business and pipeline. We made meaningful progress in bringing our medicines to more patients and advancing our pipeline. A positive study readout further strengthens our confidence in our future growth trajectory. “The positive study readout is a key milestone that highlights the potential to advance gout treatment and reinforces confidence in continued progress through 2026 and beyond,” said Guido Oelkers, President & CEO of Sobi. At Sobi, every step forward is guided by our commitment to transforming everyday life for people living with rare diseases and other serious conditions. We remain focused on advancing science and creating meaningful value for patients, families and healthcare communities. #Sobi #RareDiseases #InvestorRelations

Video Content